MPCCC Precision Oncology Seminar – Professor Sarah-Jane Dawson

Circulating tumour DNA to monitor the complexity of cancer

The use of circulating tumour DNA (ctDNA) for molecular disease monitoring has enormous potential to facilitate precision medicine and optimise cancer management across a range of malignancies. A summary of current approaches for ctDNA analysis will be presented, together with an overview of clinical applications for the use of liquid biopsies in cancer management.

Professor Sarah-Jane Dawson is a clinician-scientist. She obtained her medical degree from the University of Melbourne in 1998, and trained as a medical oncologist in Melbourne, Australia. She completed her PhD at the University of Cambridge, UK. Following postdoctoral studies at the Cancer Research UK Cambridge Institute, she returned to Melbourne in 2014 to head the Molecular Biomarkers and Translational Genomics Laboratory at the Peter MacCallum Cancer Centre. She also holds a joint appointment with the Centre of Cancer Research at The University of Melbourne (since 2016) and currently holds a CSL Centenary Fellowship (2018-2022). Her current research interests are focused on the development of noninvasive blood-based biomarkers (‘liquid biopsies’) for clinical application, including early detection, risk stratification and disease monitoring in cancer management.

Event details

1-2pm, Friday 31 July 2020

This meeting will take place on Zoom.

Zoom joining details are: https://monash.zoom.us/j/98735793824

Meeting ID: 987 3579 3824

Password: 652201

Register for online event here >>